Exhaled breath condensate: Methodological recommendations and unresolved questions

European Respiratory Journal

Volumn 26, Issue 3, 2005, Pages 523-548

  Horvath I ^a   Hunt, J ^b,d   Barnes, P J ^c   Alving, K ^d   Antczak, A ^d   Baraldi, E ^d   Becher, G ^d   van Beurden, W J C ^d   Corradi, M ^d   Dekhuijzen, R ^d   Dweik, R A ^d   Dwyer, T ^d   Effros, R ^d   Erzurum, S ^d   Gaston, B ^d   Gessner, C ^d   Greening, A ^d   Ho, L P ^d   Hohlfeld, J M ^d   Jobsis Q ^d   Laskowski, D ^d   Loukides, S ^d   Marlin, D ^d   Montuschi, P ^d   Olin, A C ^d   Redington, A E ^d   Reinhold, P ^d   van Rensen, E L J ^d   Rubinstein, I ^d   Silkoff, P ^d   Toren, K ^d   Vass, G ^d   Vogelberg, C ^d   Wirtz, H ^d   Balint, B ^d   Blomberg, A ^d   Freels, J ^d   Goldman, M ^d   Kharitonov, S A ^d   Kelly, F ^d   Lehmann, C ^d   Lindstrom, A ^d   Robbins, R ^d   Rothe, M ^d   Smith, H J ^d   Steinhaeusser, W R ^d   Teague, W G ^d   Vaughan, J ^d   more..

^a NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

^b UNIVERSITY OF VIRGINIA   (United States)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d NONE

Author keywords

Airway inflammation; Biomarkers; Exhaled breath condensate; Lung diseases; Noninvasive monitoring; Oxidative stress

Indexed keywords

ADENOSINE; AMMONIA; BIOLOGICAL MARKER; CYTOKINE; HYDROGEN PEROXIDE; ISOPROSTANE DERIVATIVE; LEUKOTRIENE DERIVATIVE; NITROGEN OXIDE; PEPTIDE DERIVATIVE;

BIOASSAY; BREATH ANALYSIS; BREATHING; CLINICAL PRACTICE; CLIP; CONSENSUS; COOLING; DILUTION; EUROPE; EVIDENCE BASED MEDICINE; EXHALATION; FILTER; HUMAN; LONGITUDINAL STUDY; LUNG DISEASE; MEDIATOR; MEDICAL EXPERT; MEDICAL SOCIETY; MODULATION; NON INVASIVE MEASUREMENT; NOSE; PH MEASUREMENT; PRIORITY JOURNAL; REPRODUCIBILITY; RESPIRATORY TRACT DISEASE; REVIEW; SALIVA; SAMPLING; TEMPERATURE MEASUREMENT; UNITED STATES;

BIOLOGICAL MARKERS; BREATH TESTS; HUMANS; LUNG DISEASES; OXIDATIVE STRESS; REPRODUCIBILITY OF RESULTS;

EID: 24644515785     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00029705     Document Type: Review

References (231)

1. Vignola AM, Rennar SI, Hargreave FE, et al. Standardised methodology of sputum induction and processing. Future directions. Eur Respir J 2002; 20: Suppl. 37, 51s-55s.
2. American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. Am J Respir Crit Care Med 1999; 160: 2104-2117.
3. Baraldi E, De Jongste JC. ERS, ATS. Measurement of exhaled nitric oxide in children 2001. Eur Respir J 2002; 20: 223-237.
4. Horváth I, MacNee W, Kelly FJ, et al. Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases. Summary of the ERS Research Seminar in Budapest, Hungary, September 1999. Eur Respir J 2001; 18: 420-430.
5. Kietzmann D, Kah R, Muller M, Burchardi H, Kettler D. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med 1993; 19: 78-81.
6. Effros RM, Hoagland KW, Bosbous M, et al. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med 2002; 65: 663-669.
7. Scheideler L, Manke HG, Schwulera U, Inacker O, Hammerle H. Detection of nonvolatile macromolecules in breath. A possible diagnostic tool? Am Rev Respir Dis 1993; 148: 778-784.
8. Fairchild CI, Stampfer JF. Particle concentration in exhaled breath. Am Ind Hyg Assoc J 1987; 48: 948-949.
9. Papineni RS, Rosenthal FS. The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 1997; 10: 105-116.
10. Fritter D, Knobler CM. Experiments and simulation of the growth of droplets on a surface (breath figures). Physical Review A 1991; 43: 2858-2869.
11. Vass G, Huszár É, Barát E, et al. Comparison of nasal and oral inhalation during exhaled breath condensate collection. Am J Respir Crit Care Med 2003; 167: 850-855.
12. Vaughan J, Ngamtrakulpanit L, Pajewski T, et al. Exhaled breath condensate pH is a robust and reproducible assay of airway chemistry. Eur Respir J 2003; 22: 889-894.
13. 2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects. Free Radic Biol Med 2001; 30: 178-186.
14. Sznajder JI, Fraiman A, Hall JB, et al. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest 1989; 96: 606-612.
15. Culpitt SV, Russell REK. The measurement of hydrogen peroxide in airway disease. Eur Respir Rev 1999; 68: 246-248.
16. Carpenter C, Price P, Christmas B. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury and ARDS. Chest 1998; 114: 1653-1659.
17. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999; 160: 216-220.
18. Ho LP, Innes JA, Greening AP. Nitrite level in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax 1998; 53: 680-684.
19. Schleiss MB, Holz O, Behnke M, Richter K, Magnussen H, Jorres RA. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. Eur Respir J 2000; 16: 111-1-4118.
20. Huszár É, Vass G, Vizi É, et al. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J 2002; 20: 1393-1398.
21. Corradi M, Rubinstein I, Andreoli R, et al. Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 1380-1386.
22. Horváth I, Donnelly LE, Kiss A, et al. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med 1998; 158: 1042-1046.
23. Mutlu GM, Garey KW, Robbins RA, Danzinger LH, Rubinstein I. Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med 2001; 164: 731-737.
24. Ganas K, Loukides S, Papatheodorou G, Panagou P, Kalogeropoulos N. Total nitrite/nitrate in expired breath condensate of patients with asthma. Respir Med 2001; 95: 649-654.
25. Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol 2002; 110: 28-34.
26. Eschenbacher WL, Sheppard D. Respiratory heat loss is not the sole stimulus for bronchoconstriction induced by isocapnic hyperpnea with dry air. Am Rev Respir Dis 1985; 131: 894-901.
27. Smith CM, Anderson SD. Hyperosmolarity as the stimulus to asthma induced by hyperventilation. J Allergy Clin Immunol 1986; 77: 729-736.
28. Gessner C, Kuhn H, Seyfarth H-J, et al. Factors influencing breath condensate volume. Pneumologie 2001; 55: 414-419.
29. Latzin P, Griese M. Exhaled hydrogen peroxide, nitrite and nitric oxide in healthy children: decrease of hydrogen peroxide by atmospheric nitric oxide. Eur J Med Res 2002; 7: 353-358.
30. 4 concentrations in exhaled condensate as a noninvasive method for assessing mediators of inflammation in the lungs of calves. Am J Vet Res 2000; 61: 742-749.
31. Mitchell JW, Nadel ER, Stolwijk JAJ. Respiratory weight losses during exercise. J Appl Physiol 1972; 32: 474-476.
32. Baraldi E, Ghiro L, Piovan V, Carraro S, Zacchello F, Zanconato S. Safety and success of exhaled breath condensate collection in asthma. Arch Dis Child 2003; 88: 358-360.
33. Jobsis Q, Raatgeep HC, Schellekens SL, Hop WC, Hermans PW, de Jongste JC. Hydrogen peroxide in exhaled air of healthy children: reference values. Eur Respir J 1998; 12: 483-485.
34. Van Beurden WCJ, Dekhuijzen PNR, Harff GA, Smeenk FWJM. Variability of exhaled hydrogen peroxide in stable COPD and matched healthy controls. Respiration 2002; 69: 211-216.
35. Guatura SB, Martinez JA, Santos Bueno PC, Santos ML. Increased exhalation of hydrogen peroxide in healthy subjects following cigarette consumption. Sao Paulo Med J 2000; 118: 93-98.
36. Cheah FC, Darlow BA, Winterbourn CC. Problems associated with collecting breath condensate for the measurement of exhaled hydrogen peroxide from neonates on respiratory support. Biol Neonate 2003; 84: 338-341.
37. Griese M, Latzin P, Beck J. A noninvasive method to collect nasally exhaled air condensate in humans of all ages. Eur J Clin Invest 2001; 31: 915-920.
38. Latzin P, Beck J, Bartenstein A, Griese M. Comparison of exhaled breath condensate from nasal and oral collection. Eur J Med Res 2003; 8: 505-510.
39. Nowak D, Antczak A, Krol M, et al. Increased content of hydrogen peroxide in the expired breath of cigarette smokers. Eur Respir J 1996; 9: 652-657.
40. Balint B, Donnelly LE, Hanazawa T, Kharitonov SA, Barnes PJ. Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke. Thorax 2001; 56: 456-461.
41. Montuschi P, Collins JV, Ciabattoni G, et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000; 162: 1175-1177.
42. Garey K, Neuhauser MM, Robbins RA, Danziger LH, Rubinstein I. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest 2004; 125: 22-26.
43. Horváth I, Donnelly LE, Kiss A, Balint B, Kharitonov SA, Barnes PJ. Exhaled nitric oxide and hydrogen peroxide concentrations in asthmatic smokers. Respiration 2004; 71: 463-468.
44. Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 1999; 93: 389-396.
45. Dekhuijzen PN, Aben KKH, Dekker L et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary diseases. Am J Respir Crit Care Med 1996; 154: 813-816.
46. Nowak D, Kasielski M, Pietras T, Bialasiewicz P, Antczak A. Cigarette smoking does not increase hydrogen peroxide levels in expired breath condensate of patients with stable COPD. Monaldi Arch Chest Dis 1998; 53: 268-267.
47. Rysz J, Kasielski M, Apanasiewicz J, et al. Increased hydrogen peroxide in the exhaled breath of uraemic patients unaffected by haemodialysis. Nephrol Dial Transplant 2004; 19: 158-163.
48. Moloney ED, Mumby SE, Gajdocsi R, et al. Exhaled breath condensate detects markers of pulmonary inflammation after cardiothoracic surgery. Am J Respir Crit Care Med 2004; 169: 64-69.
49. Vogelberg C, Hirsch T, Rosen-Wolff A, Kerkmann M-L, Leupold W. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis. Pediatr Pulmonol 2003; 36: 348-352.
50. Corradi M, Folesani G, Andreoli R, et al. Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am J Respir Crit Care Med 2003; 167: 395-399.
51. Effros RM, Biller J, Foss B, et al. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med 2003; 168: 1500-1505.
52. Zacharasiewicz A, Wilson N, Lex C, et al. Repeatability of sodium and chloride in exhaled breath condensates. Pediatr Pulmonol 2004; 37: 273-275.
53. Dwyer TM. Sampling airway surface liquid: nonvolatiles in the expired breath condensate. Lung 2004; 182: 241-250.
54. Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 1999; 14: 245-248.
55. Bland JM, Altman DG. Statistical method for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
56. Griese M, Noss J, von Bredow C. Protein pattern of exhaled breath condensate and saliva. Proteomics 2002; 2: 690-696.
57. Tornberg DC, Marteus H, Schedin U, Alving K, Lundberg JO, Weitzberg E. Nasal and oral contribution to inhaled and exhaled nitric oxide: a study in tracheotomized patients. Eur Respir J 2002; 19: 859-864.
58. Dohlman AW, Black HR, Royall JA. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. Am Rev Respir Dis 1993; 148: 955-960.
59. De Benedetto F, Aceto A, Dragani B, et al. Validation of a new technique to assess exhaled hydrogen peroxide: results from normals and COPD patients. Monaldi Arch Chest Dis 2000; 55: 185-188.
60. Jöbsis Q, Raatgeep HC, Hermans PW, de Jongste JC. Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J 1997; 10: 519-521.
61. Conner GE, Salathe M, Forteza R. Lactoperoxidase and hydrogen peroxide metabolism in the airway. Am J Respir Crit Care Med 2002; 166: S57-S61.
62. van Beurden WJ, van den Bosch MJ, Janssen WC, Smeenk FW, Dekhuijzen PN, Harff GA. Fluorimetric analysis of hydrogen peroxide with automated measurement. Clin Lab 2003; 49: 637-643.
63. Van Hoydonck PG, Wuyts WA, Vanaudenaerde BM, Schouten EG, Dupont LJ, Temme EH. Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate. Eur Respir J 2004; 23: 189-192.
64. Ho LP, Faccenda J, Innes JA, Greening AP. Expired hydrogen peroxide in breath condensate of cystic fibrosis patients. Eur Respir J 1999; 13: 103-106.
65. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 2003; 124: 1373-1380.
66. Rahman I. Reproducibility of oxidative stress biomarkers in breath condensate: are they reliable? Eur Respir J 2004; 23: 183-184.
67. Van Beurden WJ, Harff GA, Dekhuijzen PN, van den Bosch MJ, Creemers JP, Smeenk FW. An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate. Respir Med 2002; 96: 197-203.
68. Zappacosta B, Persichilli S, Mormile F, et al. A fast chemiluminescence method for hydrogen peroxide measurement in exhaled breath condensate. Clin Chim Acta 2001; 310: 187-191.
69. Razola SS, Ruiz BL, Diez NM, Mark HB Jr, Kauffmann JM. Hydrogen peroxide sensitive amperometric biosensor based on horseradish peroxidase entrapped in a polypyrrole electrode. Biosens Bioelectron 2002; 17: 921-928.
70. Thanachasai S, Rokutanzono S, Yoshida S, Watanabe T. Novel hydrogen peroxide sensors based on peroxidase-carrying poly[pyrrole-co-[4-(3-pyrrolyl)butanesulfonate]] copolymer films. Anal Sci 2002; 18: 773-777.
71. Antczak A, Nowak D, Shariati B, Krol M, Piasecka G, Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J 1997; 10: 1231-1241.
72. Antczak A, Kurmanowska Z, Kasielski M, Nowak D. Inhaled glucocorticosteroids decrease hydrogen peroxide in expired air condensate in asthmatic children. Resp Med 2000; 94: 416-421.
73. Sandrini A, Ferreira IM, Gutierrez C, Jardim JR, Zamel N, Chapman KR. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest 2003; 124: 1334-1340.
74. Ferreira IM, Hazari MS, Gutierrez C, Zamel N, Chapman KR. Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease (effect of inhaled beclomethasone). Am J Respir Crit Care Med 2001; 164: 1012-1015.
75. Kasielski M, Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Resp Med 2001; 95: 448-456.
76. Loukides S, Horvath I, Wodehouse T, Cole PJ, Barnes PJ. Elevated levels of expired breath hydrogen peroxide in bronchiectasis. Am J Respir Crit Care Med 1998; 158: 991-994.
77. 2 in steady state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of diseases. Chest 2002; 121: 81-87.
78. Worlitzsch D, Herberth G, Ulrich M, Doring G. Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis. Eur Respir J 1998; 11: 377-383.
79. Jobsis Q, Raatgeep HC, Schellekens SL, Kroesbergen A, Hop WC, de Jongste JC. Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment. Eur Respir J 2000; 16: 95-100.
80. Baldwin SR, Grum CM, Boxer LA, Ketai LH, Boxer LA, Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1986; I: 11-14.
81. Heard SO, Longtine K, Toth I, Puyana JC, Potenza B, Smyrnios N. The influence of liposome-encapsulated prostaglandin E1 on hydrogen peroxide concentrations in the exhaled breath of patients with the acute respiratory distress syndrome. Anesth Analg 1999; 89: 353-357.
82. Wilson WC, Laborde PR, Benumof JL, Taylor R, Swetland JF. Reperfusion injury and exhaled hydrogen peroxide. Anesth Analg 1993; 77: 963-970.
83. Sandrini A, Ferreira IM, Jardim JR, Zamel N, Chapman KR. Effect of nasal triamcinolone on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol 2003; 111: 313-320.
84. Jobsis Q, Schellenkens SL, Fakkel-Kroesbergen A, Raatgreep HC, de Jongste JC. Hydrogen peroxide in breath condensate during a common cold. Mediators Inflam 2001; 10: 351-354.
85. Lases EC, Duurkens VA, Gerritsen WB, Haas FJ. Oxidative stress after lung resection therapy: a pilot study. Chest 2000; 117: 999-1003.
86. Luczynska M, Szkudlarek U, Dzianowska-Bartkowiak B, et al. Elevated exhalation of hydrogen peroxide in patients with systemic sclerosis. Eur J Clin Invest 2003; 33: 274-279.
87. Wilhelm J, Vankova M, Maxova H, Siskova A. Hydrogen peroxide production by alveolar macrophages is increased and its concentration is elevated in the breath of rats exposed to hypoxia: relationship to lung lipid peroxidation. Physiol Res 2003; 52: 327-332.
88. 2 production in rats. Exp Lung Res 2003; 29: 585-592.
89. van Beurden WJ, Harff GA, Dekhuijzen PN, van der Poel-Smet SM, Smeenk FW. Effects of inhaled corticosteroids with different lung deposition on exhaled hydrogen peroxide in stable COPD patients. Respiration 2003; 70: 244-248.
90. Deaton CM, Marlin DJ, Smith NC, et al. Breath condensate hydrogen peroxide correlates with both airway cytology and epithelial lining fluid ascorbic acid concentration in the horse. Free Radic Res 2004; 38: 201-208.
91. Balint B, Kharitonov SA, Hanazawa T, et al. Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis. Eur Respir J 2001; 17: 1201-1207.
92. Cunningham S, McColm JR, Ho LP, Greening AP, Marshall TG. Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis. Eur Respir J 2000; 15: 955-957.
93. Dweik RA, Comhair SAA, Gaston B, et al. Nitric oxide chemical events in the human airway during the immediate and late antigen induced asthmatic response. Proc Natl Acad Sci USA 2001; 98: 2622-2627.
94. Kaneko FT, Arroliga AC, Dweik RA, et al. Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am J Respir Crit Care Med 1998; 158: 917-923.
95. Dziedzic B, Mazanowska-Gajdowicz J, Walczewska A, Sarniak A, Nowak D. Comparison of cadmium and enzyme-catalyzed nitrate reduction for determination of NO2-/NO3- in breath condensate. Clin Chim Acta 2003; 335: 65-74.
96. Hunt J, Byrns RE, Ignarro LJ, Gaston B. Condensed expirate nitrite as a home marker for acute asthma. Lancet 1995; 346: 1235-1236.
97. Ganas K, Loukides S, Papatheodorou G, Panagou P, Kalogeropoulos N. Total nitrite/nitrate in expired breath condensate of patients with asthma. Resp Med 2001; 95: 649-654.
98. Kharitonov SA, Donnelly LE, Montuschi P, Collins JV, Barnes PJ. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 2002; 57: 889-896.
99. Formanek W, Inci D, Lauener RP, Wildhaber JH, Frey U, Hall GL. Elevated nitrite in breath condensates of children with respiratory disease. Eur Respir J 2002; 19: 487-491.
100. Nightingale JA, Rogers DF, Chung FK, Barnes PJ. No effect of inhaled budenoside on the response to inhaled ozone in normal subjects. Am J Respir Crit Care Med 2000; 161: 479-486.
101. Corradi M, Pesci A, Casana R, et al. Nitrate in exhaled breath condensate of patients with different airway diseases. Nitric oxide 2003; 8: 26-30.
102. Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002; 165: 1364-70.
103. Corradi M, Montuschi P, Donnelly LE, Pesci A, Kharitonov SA, Barnes PJ. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med 2001; 163: 854-858.
104. Fang K, Ragsdale NV, Carey RM, MacDonald T, Gaston B. Reductive assays for S-nitrosothiols: implications for measurements in biological systems. Biochem Biophys Res Commun 1998; 252: 535-540.
105. Nightingale JA, Rogers DF, Barnes PJ. Effect of inhaled ozone on exhaled nitric oxide, pulmonary function, and induced sputum in normal and asthmatic subjects. Thorax 1999; 54: 1061-1069.
106. Csoma Z, Bush A, Wilson NM, et al. Nitric oxide metabolites are not reduced in exhaled breath condensate of patients with primary ciliary dyskinesia. Chest 2003; 124: 633-638.
107. Gessner C, Hammerschimclt S, Kuhn H, et al. Exhaled breath condensate nitrite and its relation to tidal volume in acute lung injury. Chest 2003; 124: 1046-1052.
108. Ischiropoulos H, Zhu L, Chen J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992; 298: 438-445.
109. Hanazawa T, Kharitonov SA, Barnes PJ. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 2000; 162: 1273-1276.
110. Wu W, Samoszuk M, Comhair SAA, et al. Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest 2000; 105: 1455-1463.
111. Mathews WR, Kerr SW. Biological activity of S-nitrosothiols: the role of nitric oxide. J Pharmacol Exp Ther 1993; 267: 1529-1537.
112. Fozard JR. The case for a role for adenosine in asthma: almost convincing? Curr Opin Pharmacol 2003; 3: 264-269.
113. Huszar E, Barat E, Kollai M. Isocratic high-performance liquid chromatographic determination of plasma adenosine. Chromatographia 1996; 42: 318-322.
114. Vizi É, Huszár É, Csoma Z, et al. Plasma adenosine concentration increases during exercise: a possible contributing factor to exercise-induced bronchoconstriction in asthma. J Allergy Clin Immunol 2002; 109: 446-448.
115. Driver AG, Kukoly CA, Ali A, et al. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 1993; 15: 161-165.
116. Samuelsson B, Granstrom E, Green K, Hamberg M, Hammarstrom S. Prostaglandins. Annu Rev Biochem 1975; 44: 669-695.
117. Antczak A, Montuschi P, Kharitonov SA, Gorski P, Barnes PJ. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 2002; 166: 301-306.
118. Montuschi P, Ragazzoni E, Valente S, et al. Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate. Inflamm Res 2003; 52: 502-507.
119. Montuschi P, Barnes PJ. Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 2002; 109: 615-620.
120. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Prostaglandin E2 in the expired breath condensate of patients with asthma. Eur Respir J 2003; 22: 743-747.
121. Baraldi E, Ghiro L, Piovan V, et al. Increased exhaled 8-isoprostane in childhood asthma. Chest 2003; 124: 25-31.
122. Montuschi P, Kharitonov SA, Ciabattoni G, Barnes PJ. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003; 58: 585-588.
123. Wardlaw A, Hay H, Cromwell O, Collins JV, Kay AB. Leukotrienes LTC4 and LTB4 in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 1989; 84: 19-26.
124. Claesson HE, Odlander B, Jakobssen PJ. Leukotriene B4 in the immune system. Int J Immunopharmacol 1992; 14: 441-449.
125. Csoma Zs, Kharitonov SA, Balint B, Bush A, Wilson NM, Barnes PJ. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2002; 166: 1345-1349.
126. Baraldi E, Carraro S, Alinovi R, et al. Cysteinyl-leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbation. Thorax 2003; 58: 505-509.
127. Bodini A, Peroni D, Vicentini L, et al. Exhaled breath condensate eicosanoids and sputum eosinophils in asthmatic children: a pilot study. Pediatr Allergy Immunol 2004; 15: 26-31.
128. Zanconato S, Carraro S, Corradi M, et al. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol 2004; 113: 257-263.
129. Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbation of COPD. Thorax 2003; 58: 294-298.
130. Carpagnano GE, Barnes PJ, Geddes DM, Hodson ME, Kharitonov SA. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med 2003; 167: 1109-1112.
131. Neubauer B, Struck N, Mutzbauer TS, Schotte U, Langfeldt N, Tetzl K. Leukotriene-B4 concentrations in exhaled breath condensate and lung function after thirty minutes of breathing technically dried compressed air. Int Marit Health 2002; 53: 93-101.
132. Becher G, Winsel K, Beck E, Neubauer G, Stresemann E. Leukotriene B4 in breathing condensate of patients with bronchopulmonary diseases and of normal patients. Appl Cardiopulmon Pathophysiol 1995; 5: 215-219.
133. 4 measurements in exhaled breath condensate. Inflamm Res 2003; 52: 69-73.
134. Janssen LJ. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 2001; 280: 1067-1082.
135. Montuschi P, Ciabattoni G, Paredi P, et al. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 1998; 158: 1524-1527.
136. Montuschi P, Kharitonov SA, Ciabattoni G, et al. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000; 55: 205-209.
137. Psathakis K, Papatheodorou G, Plataki M, et al. 8-Isoprostane, a marker of oxidative stress, is increased in the expired breath condensate of patients with pulmonary sarcoidosis. Chest 2004; 125: 1005-1011.
138. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest 2002; 122: 1162-1167.
139. Montuschi P, Nightingale J, Kharitonov SA, Barnes PJ. Ozone-induced increase in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budenoside. Free Radic Biol Med 2002; 33: 1403-1408.
140. Mates M. Effects of antioxidant enzymes in the molecular control of ROS toxicology. Toxicol 2000; 153: 83-104.
141. Larstad M, Ljungkvist G, Olin AC, Toren K. Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl 2002; 766: 107-114.
142. Corradi M, Folesani G, Andreoli R, et al. Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am J Respir Crit Care Med 2003; 167: 395-399.
143. Hunt JF, Fang K, Malik R, et al. Endogenous airway acidification: implications for asthma pathophysiology. Am J Respir Crit Care Med 2000; 161: 694-699.
144. Effros RM, Hunt J, Gaston B. Endogenous airway acidification: implications for asthma pathology. Am J Respir Crit Care Med 2001; 163: 293-294.
145. Wells K, Vaughan J, Pajewski TN, et al. Exhaled breath condensate pH assays not influenced by oral ammonia. Thorax 2005; 60: 27-31.
146. Tate S, MacGregor G, Davis M, Innes JA, Greening AP. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 2002; 57: 926-929.
147. Gessner C, Hammerschmidt S, Kuhn H, et al. Exhaled breath acidification in acute lung injury. Respir Med 2003; 97: 1188-1194.
148. Hunt JF, Erwin E, Palmer L, et al. Expression and activity of pH-regulatory glutaminase in the human airway epithelium. Am J Respir Crit Care Med 2002; 165: 101-107.
149. Effros RM. Do low exhaled condensate NH4+ concentrations in asthma reflect reduced pulmonary production? Am J Respir Crit Care Med 2003; 167: 91-92.
150. Norwood DM, Waiman T, Lioy PJ, Waldman JM. Breath ammonia depletion and its relevance to acidic aerosol exposure studies. Arch Environ Health 1992; 47: 309-313.
151. Laberge S, El Bassam S. Cytokines, structural cells of the lungs and airway inflammation. Paediatr Respir Rev 2004; 5: Suppl. A, S41-S45.
152. Shahid SK, Kharitonov SA, Wilson NM, Bush A, Barnes PJ. Increased interleukin-4 and decreased interferon-γ in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med 2002; 165: 1290-1293.
153. Carpagnano GE, Resta O, Foscino-Brabaro MP, Gramiccioni E, Carpagnano F. Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer. Int J Biol Markers 2002; 17: 141-145.
154. Bucchioni E, Kharitonov SA, Allegra L, Barnes PL. High levels of interleukin-6 in the exhaled breath condensate in patients with COPD. Respir Med 2003; 97: 1299-1302.
155. Carpagnano Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J 2003; 21: 589-593.
156. McRae K, De Perrot M, Fischer S, Waddell TK, Liu M, Keshavjee S. Detection of IL-10 in the exhaled breath condensate, plasma and tissue during ischemia-reperfusion injury in experimental lung transplantation. J Heart Lung Transplant 2001; 20: 184.
157. Gessner C. Detection of mutations of the K-ras gene in condensed breath of patients with non small cell lung cancer (NSLC) as a possible non-invasive screening method. Pneumologie 1998; 52: 426-427.
158. Gessner C, Kuhn H, Toepfer K, Hammersmidt S, Schauer J, Wirtz H. Detection of p53 mutations in exhaled breath condensate of non small cell lung cancer patients. Lung Cancer 2004; 43: 215-222.
159. Nayeri F, Millinger E, Nilsson I, Zetterstrom, Brudin L, Forsberg P. Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia. Respir Med 2002; 96: 115-119.
160. Carpagnano GE, Kharitonov SA, Wells A, Pantelidis P, Du Bois RM, Barnes PJ. Increased vitronectin and endothelin-1 in the breath condensate of patients with fibrosing lung disease. Respiration 2003; 70: 154-160.
161. Schreiber J, Meyer C, Rusch-Gerdes S, et al. Mycobacterium tuberculosis gene-amplification in breath condensate of patients with lung tuberculosis. Eur J Med Res 2002; 7: 290-291.
162. Stockley RA, Baylay DL. Validation of assays for inflammatory mediators in sputum. Eur Respir J 2000; 15: 778-781.
163. Gibson PG, Henry RL, Thomas P. Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate. Eur Respir J 2000; 16: 1008-1015.
164. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1693-1722.
165. Kharitonov SA, Barnes PJ. Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers 2002; 7: 1-32.
166. Montuschi P, Barnes PJ. Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci 2002; 23: 232-237.
167. Montuschi P. Indirect monitoring of lung inflammation. Nat Rev Drug Discov 2002; 1: 238-242.
168. Wilson N. Measurement of airway inflammation in asthma. Curr Opin Pulm Med 2002; 1: 25-32.
169. Paredi P, Kharitonov SA, Barnes PJ. Analysis of expired air for oxidant products. Am J Respir Crit Care Med 2002; 166: S31-S37.
170. Horvath I. Exhaled breath condensate in disease monitoring. Clin Pulm Med 2003; 10: 195-200.
171. Antczak A, Gorski P. Markers of pulmonary diseases in exhaled breath condensate. Int J Occup Med Environ Health 2002; 15: 317-323.
172. Rosias PP, Dompeling E, Hendriks HJ, Heijnens JW, Donckerwolcke RA, Jobsis Q. Exhaled breath condensate in children: pearls and pitfalls. Pediatr Allergy Immunol 2004; 15: 4-19.
173. Dwyer TM. Cigarette smoke-induced airway inflammation as sampled by the expired breath condensate. Am J Med Sci 2003; 326: 174-178.
174. Hyde RW. "I don't know what you guys are measuring but you sure are measuring it!" A fair criticism of measurements of exhaled condensates? Am J Respir Crit Care Med 2002; 165: 561-564.
175. Griffith OW. Glutaminase and the control of airway pH. Yet another problem for asthmatic lung? Am J Respir Crit Care Med 2002; 165: 1-3.
176. Horváth I. Exhaled breath condensate contains more than only volatiles. Eur Respir J 2003; 22: 187-188.
177. Risby TH. Further discussion on breath condensate analysis. Am J Respir Crit Care Med 2003; 167: 1301-1303.
178. Mutti A, Corradi M, Rubinstein I. Reporting data on exhaled breath condensate. Am J Respir Crit Care Med 2003; 168: 719-720.
179. Effros RM. Saving the breath condensate approach. Am J Respir Crit Care Med 2003; 168: 1129-1132.
180. Spicuzza L, Di Maria GU, Polosa R. Adenosine levels in the exhaled breath condensate: a potential surrogate marker of airway inflammation. Eur Respir J 2003; 22: 392-393.
181. Gaston B. Breath condensate analysis. Perhaps worth studying after all. Am J Respir Crit Care Med 2003; 167: 292.
182. Montuschi P, Martello S, Felli M, Mondino C, Chiarotti M. Ion trap liquid chromatography/tandem mass spectrometry analysis of leukotriene B(4) in exhaled breath condensate. Rapid Commun Mass Spectrom 2004; 18: 2723-2729.
183. Neubauer B, Schotte U, Struck N, Langfeldt N, Mutzbauer TS. Leukotriene-B4 concentrations in breathing condensate before and after simulated deep dives. Undersea Hyperb Med 2004; 31: 217-224.
184. Mondino C, Ciabattoni G, Koch P, et al. Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. J Allergy Clin Immunol 2004; 114: 761-767.
185. Hitka P, Cerny M, Vizek M, Wilhelm J, Zoban P. Assessment of exhaled gases in ventilated preterm infants. Physiol Res 2004; 53: 561-564.
186. Griese M, Noss J, Schramel P. Elemental and ion composition of exhaled AIR condensate in cystic fibrosis. J Cyst Fibros 2003; 2: 136-142.
187. Sparkes AH, Mardell EJ, Deaton C, Kirschvink N, Marlin D. Exhaled breath condensate (EBC) collection in cats-description of a non-invasive technique to investigate airway disease. J Feline Med Surg 2004; 6: 335-338.
188. Goldoni M, Catalani S, De Palma G, et al. Exhaled breath condensate as a suitable matrix to assess lung dose and effects in workers. Environ Health Perspect 2004; 112: 1293-1298.
189. Rahman I, Biswas SK. Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues. Redox Rep 2004; 9: 125-143.
190. Svensson S, Olin AC, Larstad M, Ljungkvist G, Toren K. Determination of hydrogen peroxide in exhaled breath condensate by flow injection analysis with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 809: 199-203.
191. Leung TF, Li CY, Lam CW, et al. The relation between obesity and asthmatic airway inflammation. Pediatr Allergy Immunol 2004; 15: 344-350.
192. McCafferty JB, Bradshaw TA, Tate S, Greening AP, Innes JA. Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations. Thorax 2004; 59: 694-698.
193. Majewska E, Kasielski M, Luczynski R, Bartosz G, Bialasiewicz P, Nowak D. Elevated exhalation of hydrogen peroxide and thiobarbituric acid reactive substances in patients with community acquired pneumonia. Respir Med 2004; 98: 669-676.
194. Bucchioni E, Csoma Z, Allegra L, Chung KF, Barnes PJ, Kharitonov SA. Adenosine 5′-monophosphate increases levels of leukotrienes in breath condensate in asthma. Respir Med 2004; 98: 651-655.
195. Niimi A, Nguyen LT, Usmani O, Mann B, Chung KF. Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough. Thorax 2004; 59: 608-612.
196. Carpagnano GE, Foschino-Barbaro MP, Resta O, Gramiccioni E, Carpagnano F. Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer. Oncology 2004; 66: 180-184.
197. Rosias PP, Dompeling E, Dentener MA, et al. Childhood asthma: exhaled markers of airway inflammation, asthma control score, and lung function tests. Pediatr Pulmonol 2004; 38: 107-114.
198. Gianazza E, Allegra L, Bucchioni E, et al. Increased keratin content detected by proteomic analysis of exhaled breath condensate from healthy persons who smoke. Am J Med 2004; 117: 51-54.
199. Carpagnano GE, Barnes PJ, Francis J, Wilson N, Bush A, Kharitonov SA. Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation? Chest 2004; 125: 2005-2010.
200. Cap P, Chladek J, Pehal F, et al. Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients. Thorax 2004; 59: 465-470.
201. Leung TF, Wong GW, Ko FW, Lam CW, Fok TF. Increased macrophage-derived chemokine in exhaled breath condensate and plasma from children with asthma. Clin Exp Allergy 2004; 34: 786-791.
202. Back EI, Frindt C, Nohr D, et al. Antioxidant deficiency in cystic fibrosis: when is the right time to take action? Am J Clin Nutr 2004; 80: 374-384.
203. Effros RM, Dunning M, Biller J, Shaker R. The promise and perils of exhaled breath condensates. Am J Physiol (Lung Cell Mol Biol) 2004; 287: L1073-L1080.
204. Dwyer TM. Sampling airway surface liquid: Nonvolatiles in the expired breath condensate. Lung 2004; 182: 241-250.
205. Ojoo JC, Mulrennan SA, Kastelik JA, Morice AH, Redington AE. Exhaled breath condensate PH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax 2005; 60: 22-26.
206. Hunt JF. Informative complexity of exhaled nitrogen oxide chemistry. Seeking the meaning of exhaled NO. Thorax 2005; 60: 2-3.
207. Borill Z, Starkey C, Vestbo J, Singh D. Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. Eur Respir J 2005; 25: 269-274.
208. Zacharasiewicz A, Wilson N, Lex C, et al. Clinical use of non-invasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005; 171: 1077-1082.
209. Effros RM, Su J, Casaburi R, Shaker R, Biller J, Dunning M. Utility of exhaled breath condensates in chronic obstructive pulmonary disease: a critical review. Curr Opin Pulm Med 2005; 11: 135-139.
210. Gerritsen WB, Asin J, Zanen P, van den Bosch JM, Haas FJ. Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir Med 2005; 99: 84-90.
211. Sanak M, Kielbasa B, Bochenek G, Szczeklik A. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients. Clin Exp Allergy 2004; 34: 1899-1904.
212. Cap P, Pehal F, Chladek J, Maly M. Analysis of exhaled leukotrienes in nonasthmatic adult patients with seasonal allergic rhinitis. Allergy 2005; 60: 171-176.
213. Wyse CA, Hammond J, Arteaga A, et al. Collection and analysis of exhaled breath condensate hydrogen peroxide in conscious healthy dogs. Vet Rec 2004; 155: 744-746.
214. Harrison CM, Andersen CC. Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease? Arch Dis Child Fetal Neonatal Ed 2005; 90: F6-F10.
215. Svensson S, Isacsson AC, Ljungkvist G, Toren K, Olin AC. Optimization and validation of an ion chromatographic method for the simultaneous determination of sodium, ammonium and potassium in exhaled breath condensate. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 814: 173-177.
216. Corradi M, Pignatti P, Manini P, et al. Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation. Eur Respir J 2004; 24: 1011-1017.
217. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ. Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation. Thorax 2004; 59: 1016-1019.
218. Troosters T. Oxygen: the good, the bad, and the necessary. Thorax 2004; 59: 1005-1006.
219. Carpagnano GE, Resta O, Foschino-Barbaro MP, et al. Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys). Eur J Pharmacol 2004; 505: 169-175.
220. 2) levels in exhaled breath condensate in 9-year-old healthy children. Pediatr Pulmonol 2005; 39: 41-45.
221. Montuschi P, Martello S, Felli M, Mondino C, Chiarotti M. Ion trap liquid chromatography/tandem mass spectrometry analysis of leukotriene B4 in exhaled breath condensate. Rapid Commun Mass Spectrom 2004; 18: 2723-2729.
222. Hitka P, Cerny M, Vizek M, Wilhelm J, Zoban P. Assessment of exhaled gases in ventilated preterm infants. Physiol Res 2004; 53: 561-564.
223. Sparkes AH, Mardell EJ, Deaton C, Kirschvink N, Marlin D. Exhaled breath condensate (EBC) collection in cats - description of a non-invasive technique to investigate airway disease. J Feline Med Surg 2004; 6: 335-338.
224. Goldoni M, Catalani S, De Palma G, et al. Exhaled breath condensate as a suitable matrix to assess lung dose and effects in workers exposed to cobalt and tungsten. Environ Health Perspect 2004; 112: 1293-1298.
225. Rosias P, Robroeks C, Hendriks, J, Dompeling E, Jobsis Q. Exhaled breath condensate: a space odessey, where no one has gone before. Eur Respir J 2004; 24: 189-190.
226. Csoma Z, Huszár E, Vizi E, et al. Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction. Eur Respir J 2005; 25: 873-884.
227. Horváth I. The exhaled biomarker puzzle: bacteria play their card in the exhaled nitric oxide - exhaled breath condensate nitrite game. Thorax 2005; 60: 179-180.
228. Marteus H, Törnberg DC, Weitzberg E, Schedin U, Alving K. Origin of nitrite and nitrate in nasal and exhaled breath condensate, and the relation to nitric oxide formation. Thorax 2005; 60: 219-225.
229. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002; 1: 153-161.
230. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 2002; 8: 1439-1444.
231. Razola SS, Ruiz BL, Diez NM, Mark HB Jr, Kauffmann JM. Hydrogen peroxide sensitive amperometric biosensor based on horseradish peroxidase entrapped in a polypyrrole electrode. Biosens Bioelectron 2002; 17: 921-928.